Prescription drug · ANDA
Paroxetine NDC 63187-564
Paroxetine hydrochloride hemihydrate 20 mg/1 · Tablet, Film coated · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63187-564-30 | 63187056430 | 30 TABLET, FILM COATED in 1 BOTTLE (63187-564-30)Marketed from Dec 1, 2018 | |
| 63187-564-60 | 63187056460 | 60 TABLET, FILM COATED in 1 BOTTLE (63187-564-60)Marketed from Dec 1, 2018 | |
| 63187-564-90 | 63187056490 | 90 TABLET, FILM COATED in 1 BOTTLE (63187-564-90)Marketed from Dec 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Paroxetine
- Generic name (nonproprietary)
- paroxetine
- Active ingredients
- Paroxetine hydrochloride hemihydrate — 20 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078406
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 63187-564_4637d56c-fd38-47ea-b814-4d87a7d36f1fSPL ID 4637d56c-fd38-47ea-b814-4d87a7d36f1fSPL set ID 847118ec-c139-466c-834b-1ae0b6e1f791RxCUI 1738495UNII X2ELS050D8
- Pharmacologic class
- Serotonin Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463187056430followed by a unit qualifier and the quantityPackage 63187-0564-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Major Depressive Disorder Paroxetine tablets, USP are indicated for the treatment of major depressive disorder. The efficacy of paroxetine in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the DSM-III category of major depressive disorder (see CLINICAL PHARMACOLOGY: Clinical Trials ). A major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: Change in appetite, change in sleep, psychom…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 078406
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Paroxetine | Paroxetine hydrochloride hemihydrate 40 mg/1 | Tablet, Film coatedOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-056 |
| Paroxetine | Paroxetine hydrochloride 10 mg/1 | Tablet, Film coatedOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8359 |
| Paroxetineparoxetine hydrochloride | Paroxetine hydrochloride hemihydrate 40 mg/1 | Tablet, Film coatedOral | NorthStar Rx LLC | 16714-184 |
| Paroxetineparoxetine hydrochloride | Paroxetine hydrochloride hemihydrate 10 mg/1 | Tablet, Film coatedOral | NorthStar Rx LLC | 16714-181 |
| Paroxetineparoxetine hydrochloride | Paroxetine hydrochloride hemihydrate 20 mg/1 | Tablet, Film coatedOral | NorthStar Rx LLC | 16714-182 |
| Paroxetineparoxetine hydrochloride | Paroxetine hydrochloride hemihydrate 30 mg/1 | Tablet, Film coatedOral | NorthStar Rx LLC | 16714-183 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 10 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-640 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 30 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-642 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 40 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-643 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 20 mg/1 | Tablet, Film coatedOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-713 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 10 mg/1 | Tablet, Film coatedOral | Aurolife Pharma LLC | 13107-154 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 20 mg/1 | Tablet, Film coatedOral | Aurolife Pharma LLC | 13107-155 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 30 mg/1 | Tablet, Film coatedOral | Aurolife Pharma LLC | 13107-156 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 40 mg/1 | Tablet, Film coatedOral | Aurolife Pharma LLC | 13107-157 |
| Paroxetine | Paroxetine hydrochloride hemihydrate 10 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-2574 |
| Paroxetineparoxetine hydrochloride | Paroxetine hydrochloride hemihydrate 40 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-157 |
| Paroxetineparoxetine hydrochloride | Paroxetine hydrochloride hemihydrate 10 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-154 |
| Paroxetineparoxetine hydrochloride | Paroxetine hydrochloride hemihydrate 20 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-155 |
| Paroxetineparoxetine hydrochloride | Paroxetine hydrochloride hemihydrate 30 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-156 |